NATALIE CULPEPPER: Open Payments
NPI 1285027433 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 16 payments from 10 companies in 2025. Trend: 2023 $148 · 2024 $83 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Lilly USA, LLC | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: CAPLYTA, MOUNJARO, BREZTRI, Omnipod, JOURNAVX, Cologuard Collection Kit, Qelbree, ZURZUVAE.
Industry payments across LA — which companies pay providers there.
